Gian Life Care Ltd
Fundamental Score
Gian Life Care Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of GIANLIFE across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Risk Factors
9 factors identified
Below-Average Return on Equity (-0.21%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (2.40%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-44.44%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-56.06%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Weak Interest Coverage (0.93x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
High Share Pledging Risk (61.17%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns or margin calls.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Gian Life Care Ltd
About GIANLIFE
Business Overview
Gian Life Care Limited provides diagnostic and related healthcare tests and services primarily in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also provides various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers. The company was incorporated in 2018 and is based in Kanpur, India.
Company Details
Key Leadership
GIANLIFE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Gian Life Care Ltd (GIANLIFE)?
As of 29 Jan 2026, 10:33 am IST, Gian Life Care Ltd (GIANLIFE) is currently trading at ₹9.72. The stock has a market capitalization of ₹10.98 (Cr).
Is GIANLIFE share price Overvalued or Undervalued?
GIANLIFE is currently trading at a P/E ratio of 0.00x, compared to the industry average of 39.28x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Gian Life Care Ltd share price?
Key factors influencing GIANLIFE's price include its quarterly earnings growth (Sales Growth: -56.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Gian Life Care Ltd a good stock for long-term investment?
Gian Life Care Ltd shows a 5-year Profit Growth of N/A% and an ROE of -0.21%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.30 before investing.
How does Gian Life Care Ltd compare with its industry peers?
Gian Life Care Ltd competes with major peers in the Healthcare Service Provider. Investors should compare GIANLIFE's P/E of 0.00x and ROE of -0.21% against the industry averages to determine its competitive standing.
What is the P/E ratio of GIANLIFE and what does it mean?
GIANLIFE has a P/E ratio of N/Ax compared to the industry average of 39.28x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is GIANLIFE performing according to Bull Run's analysis?
GIANLIFE has a Bull Run fundamental score of N/A/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does GIANLIFE belong to?
GIANLIFE operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Gian Life Care Ltd.
What is Return on Equity (ROE) and why is it important for GIANLIFE?
GIANLIFE has an ROE of -0.21%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Gian Life Care Ltd generates profits from shareholders' equity.
How is GIANLIFE's debt-to-equity ratio and what does it indicate?
GIANLIFE has a debt-to-equity ratio of 0.30, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is GIANLIFE's dividend yield and is it a good dividend stock?
GIANLIFE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has GIANLIFE grown over the past 5 years?
GIANLIFE has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GIANLIFE and why does it matter?
Promoters hold 32.09% of GIANLIFE shares, with 61.17% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is GIANLIFE's market capitalization category?
GIANLIFE has a market capitalization of ₹11 crores, placing it in the Small-cap category.
How volatile is GIANLIFE stock?
GIANLIFE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for GIANLIFE?
GIANLIFE has a 52-week high of ₹N/A and low of ₹N/A.
What is GIANLIFE's operating profit margin trend?
GIANLIFE has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is GIANLIFE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -56.06% and YoY Profit Growth of -44.44%.
What is the institutional holding pattern in GIANLIFE?
GIANLIFE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.